IR LIBRARY News & Press Releases 02/25 IR FYE2019 Financial Results Analyst Meeting presentation 02/20 PR Acucela Announces Launch of New Corporate Brand Name and Identity 02/13 PR Acucela Provides Update on Emixustat Phase 3 Clinical Trial in Patients with Stargardt Disease 02/03 PR Acucela Meets with NASA and TRISH for Phase 1 Update for SS-OCT Project more info For information on SEC filings, please visit U.S. SEC's EDGAR service. CEO Message Corporate Governance SEC Filings Shareholders Meeting IR Presentations Financial Events Calendar FAQs Email Alerts
